Dyne Therapeutics earnings were -$367.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest DYN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$115.4M, up 28.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DYN reported annual earnings of -$317.4M, with 34.5% growth.
What were Dyne Therapeutics's earnings last quarter?
On DYN's earnings call on Invalid Date, Dyne Therapeutics (NASDAQ: DYN) reported Q1 2025 earnings per share (EPS) of -$1.05, up 29.63% year over year. Total DYN earnings for the quarter were -$115.36 million. In the same quarter last year, Dyne Therapeutics's earnings per share (EPS) was -$0.81.
As of the last Dyne Therapeutics earnings report, Dyne Therapeutics is currently losing money. Dyne Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$367.13 million, a 42.63% increase year over year.
What was DYN's earnings growth in the past year?
As of Dyne Therapeutics's earnings date in Invalid Date, Dyne Therapeutics's earnings has grown year over year. DYN earnings in the past year totalled -$367.13 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.